$1.1 Billion Worldwide Metagenomic Sequencing Industry to 2027 - Impact of COVID-19 on the Market

The "Metagenomic Sequencing - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Amid the COVID-19 crisis, the global market for Metagenomic Sequencing estimated at US$1.1 Billion in the year 2020, is projected to reach a revised size of US$3.2 Billion by 2027, growing at a CAGR of 15.9% over the analysis period 2020-2027.

Reagents & Consumables, one of the segments analyzed in the report, is projected to record a 16.7% CAGR and reach US$1.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 15.8% CAGR for the next 7-year period.

The U.S. Market is Estimated at $306.8 Million, While China is Forecast to Grow at 20.6% CAGR

The Metagenomic Sequencing market in the U.S. is estimated at US$306.8 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$742.4 Million by the year 2027 trailing a CAGR of 20.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.3% and 14% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 12.5% CAGR.

Services Segment to Record 15.2% CAGR

In the global Services segment, USA, Canada, Japan, China and Europe will drive the 14.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$169.4 Million in the year 2020 will reach a projected size of US$430.9 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$492 Million by the year 2027, while Latin America will expand at a 16.9% CAGR through the analysis period.

Select Competitors (Total 35 Featured):

• BGI Group

• DNAStar, Inc.

• Eurofins Scientific

• GENEWIZ

• Illumina, Inc.

• IntegraGen SA

• Macrogen, Inc.

• Microsynth AG

• Novogene Corporation

• NuGEN Technologies, Inc.

• Oxford Nanopore Technologies Ltd.

• PerkinElmer

• QIAGEN N.V.

• Thermo Fisher Scientific, Inc.

• Zymo Research Corporation

Key Topics Covered: 

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• Influencer Market Insights

• World Market Trajectories

• Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

• UNITED STATES

• CANADA

• JAPAN

• CHINA

• EUROPE

• FRANCE

• GERMANY

• ITALY

• UNITED KINGDOM

• SPAIN

• RUSSIA

• REST OF EUROPE

• ASIA-PACIFIC

• AUSTRALIA

• INDIA

• SOUTH KOREA

• REST OF ASIA-PACIFIC

• LATIN AMERICA

• ARGENTINA

• BRAZIL

• MEXICO

• REST OF LATIN AMERICA

• MIDDLE EAST

• IRAN

• ISRAEL

• SAUDI ARABIA

• UNITED ARAB EMIRATES

• REST OF MIDDLE EAST

• AFRICA

IV. COMPETITION

• Total Companies Profiled: 35